EMAIL THIS PAGE TO A FRIEND

Nanoscale research letters

In vitro performance of lipid-PLGA hybrid nanoparticles as an antigen delivery system: lipid composition matters.


PMID 25232295

Abstract

Due to the many beneficial properties combined from both poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) and liposomes, lipid-PLGA hybrid NPs have been intensively studied as cancer drug delivery systems, bio-imaging agent carriers, as well as antigen delivery vehicles. However, the impact of lipid composition on the performance of lipid-PLGA hybrid NPs as a delivery system has not been well investigated. In this study, the influence of lipid composition on the stability of the hybrid NPs and in vitro antigen release from NPs under different conditions was examined. The uptake of hybrid NPs with various surface charges by dendritic cells (DCs) was carefully studied. The results showed that PLGA NPs enveloped by a lipid shell with more positive surface charges could improve the stability of the hybrid NPs, enable better controlled release of antigens encapsulated in PLGA NPs, as well as enhance uptake of NPs by DC.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

P6354
1,2-Dioleoyl-sn-glycero-3-phosphocholine, lyophilized powder
C44H84NO8P
270997
Dichloromethane, anhydrous, ≥99.8%, contains 40-150 ppm amylene as stabilizer
CH2Cl2
439223
Dichloromethane, for HPLC, ≥99.9%, contains 40-150 ppm amylene as stabilizer
CH2Cl2
270563
Dichloromethane, ≥99.9%
CH2Cl2
66742
Dichloromethane, Selectophore, ≥99.5%
CH2Cl2
02575
Dichloromethane, analytical standard
CH2Cl2
48538
Dichloromethane, analytical standard, stabilized
CH2Cl2
07-2205
Dichloromethane, suitable for PCB analysis
CH2Cl2
07-2206
Dichloromethane, JIS 5000, for residue analysis
CH2Cl2
07-2230
Dichloromethane, for HPLC
CH2Cl2
48600
Dichloromethane solution, certified reference material, 200 μg/mL in methanol
CH2Cl2
40042
Dichloromethane solution, certified reference material, 5000 μg/mL in methanol
CH2Cl2
723851
Dichloromethane solution, contains 10 % (v/v) methanol
CH2Cl2
03609
Ethylenediaminetetraacetic acid, BioUltra, ≥99.0% (KT)
C10H16N2O8
03620
Ethylenediaminetetraacetic acid, ≥98.0% (KT)
C10H16N2O8
03690
Ethylenediaminetetraacetic acid solution, BioUltra, for molecular biology, pH 8.0, ~0.5 M in H2O
C10H16N2O8
M1550000
Methylene chloride, European Pharmacopoeia (EP) Reference Standard
CH2Cl2
PHR1557
Methylene Chloride, Pharmaceutical Secondary Standard; Certified Reference Material
CH2Cl2
R6626
Rhodamine B, ≥95% (HPLC)
C28H31ClN2O3
83689
Rhodamine B, for fluorescence
C28H31ClN2O3
79754
Rhodamine B, analytical standard
C28H31ClN2O3
02558
Rhodamine B solution, 0.2% in isopropanol, for TLC derivatization
C28H31ClN2O3
S1827
Sodium deoxycholate, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production
C24H39NaO4
71726
Sodium dodecyl sulfate, for ion pair chromatography, ≥99.0%
C12H25NaO4S
Y0000620
Sodium laurilsulfate, European Pharmacopoeia (EP) Reference Standard
C12H25NaO4S
T9159
Trichloroacetic acid, BioXtra, ≥99.0%
C2HCl3O2
T6399
Trichloroacetic acid, ACS reagent, ≥99.0%
C2HCl3O2
T4885
Trichloroacetic acid, ≥99.0% (titration)
C2HCl3O2
T8657
Trichloroacetic acid, for electrophoresis, suitable for fixing solution (for IEF and PAGE gels), ≥99%
C2HCl3O2
91228
Trichloroacetic acid, BioUltra, ≥99.5% (T)
C2HCl3O2